| Pharmacological Treatments for Cocaine Dependence: Is there Something New? | |
| | |
MedLine Citation:
|
PMID: 21524259 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Introduction: There is no specific and approved treatment, by regulatory authorities, for cocaine dependence. Therefore, developing new medications for the treatment of this disease continues to be a research priority. Recent advances in neurobiology and brain imaging studies have suggested several promising pharmacological approaches. Materials and Methods: Literature searches were conducted for the period from January 1990 to February 2011 using PubMed, EMBASE, PsycInfo, the NIDA research monograph index and the reference list of clinicaltrials.gov, which are the main electronic sources of ongoing trials. Results: Recent controlled clinical studies have highlighted some very promising medications, especially glutamatergic (N-Acetylcysteine, modafinil, topiramate) and GABAergic (vigabatrin) agents, agonist replacement therapy (sustained-release methylphenidate, d-amphetamine) and dopamine agents (disulfiram). Aripiprazole is also a potential treatment candidate for cocaine dependence. Additionally, immunotherapy is a new and promising pharmacological approach. Conclusion: Promising pharmacological approaches have emerged for the treatment of cocaine dependence, but larger, randomized, placebo-controlled studies are needed for some medications. Preclinical studies suggest new targets of interest in cocaine dependence. The optimal therapeutic platform is the combination of pharmacotherapies with behavioral therapies. |
| | |
Authors:
|
Laurent Karila; Michel Reynaud; Henri-Jean Aubin; Benjamin Rolland; Dewi Guardia; Olivier Cottencin; Amine Benyamina |
Related Documents
:
|
21359109 - Adoption and implementation of medications in addiction treatment programs. 21673329 - Intra-articular therapy to treat septic arthritis in a dog. 18474699 - Treating the common cold during pregnancy. 16208359 - Entomology: asian honeybees parasitize the future dead. 21142259 - Adverse effects and tolerability of medications for the treatment of tobacco use and de... 9197799 - Choices and motivations of infertile couples. 275279 - Safety of hibitane. ii. human experience. 12846349 - Venous thromboembolic risk and prevention in acute medical illness. 21817849 - Building medical ethics education to improve japanese medical students' attitudes towar... |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-4-28 |
Journal Detail:
|
Title: Current pharmaceutical design Volume: - ISSN: 1873-4286 ISO Abbreviation: - Publication Date: 2011 Apr |
Date Detail:
|
Created Date: 2011-4-28 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9602487 Medline TA: Curr Pharm Des Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
Addiction Research and Treatment Center, Paul-Brousse Hospital (Assistance Publique-Hôpitaux de Paris [AP-HP]), Villejuif, France. laurent.karila@gmail.com. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Review on the Protective Effects of PACAP in Models of Neurodegenerative Diseases In vitro and In vi...
Next Document: The Potential Interest of Topiramate in Addiction.